[Federal Register Volume 72, Number 79 (Wednesday, April 25, 2007)]
[Notices]
[Pages 20552-20553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-7882]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers of Disease Control and Prevention
[Docket Number NIOSH-099]
Notice of Public Meeting and Availability for Public Comment
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the following meeting and request for public comment on the
following draft document: ``Asbestos and Other Mineral Fibers: A
Roadmap for Scientific Research.'' The document can be found at http://www.cdc.gov/niosh/review/public/099/. Instructions are provided for
submitting comments.
Public Comment Period: February 28 through May 31, 2007.
Public Meeting Date and Time: May 4, 2007, 9 a.m.-4 p.m.
Place: Holiday Inn Capitol, 550 C Street SW., Washington, DC 20024.
Purpose of Meeting: To discuss and obtain comments on the draft
document, ``Asbestos and Other Mineral Fibers: A Roadmap for Scientific
Research''. Special emphasis will be placed on discussion of the
following:
(1) Whether the hazard identification and discussion of health
effects for asbestos and mineral fibers are a reasonable reflection of
the current understanding of the evidence in the scientific literature,
(2) The appropriateness and relevancy of the discussion of the
current understanding of the analytical issues and the research needs
for analysis of asbestos and mineral fibers,
(3) The appropriateness and relevancy of the discussion of the
current understanding of the epidemiological issues and the research
needs for understanding the health effects of asbestos and mineral
fibers,
(4) The appropriateness and relevancy of the discussion of the
current understanding of the toxicological issues and the research
needs for
[[Page 20553]]
understanding the health effects of asbestos and mineral fibers, and
(5) The appropriateness and relevancy of the discussion of the path
forward and whether the ultimate vision is a reasonable outcome for the
proposed research strategy for asbestos and mineral fibers.
Status: The forum will include scientists and representatives from
various government agencies, industry, labor, and other stakeholders,
and is open to the public, limited only by the space available. Persons
wanting to attend and provide oral comments at the meeting are
requested to notify Diane Miller no later than May 1, 2007 to reserve
time for their comments. Those interested in attending without
providing oral comments at the meeting also are requested to notify Ms.
Miller by May 1, 2007 to reserve a seat. Ms. Miller can be reached by
telephone at 513/533-8450 or by e-mail at [email protected].
Priority for attendance will be given to those providing oral comments.
Other requests to attend the meeting will then be accommodated on a
first-come basis. Unreserved walk-in attendees will be accommodated on
the day of the meeting if space is available.
Persons wanting to provide oral comments will be permitted up to 15
minutes. If additional time becomes available, presenters will be
notified. Oral comments given at the meeting will be recorded and
included in the docket. Written comments will also be accepted at the
meeting. Written comments may also be submitted to Diane Miller, Robert
A. Taft Laboratories, 4676 Columbia Parkway, MS C-34, Cincinnati, Ohio
45226, telephone 513/533-8450. All material submitted to the Agency
should reference docket number NIOSH-099 and must be submitted by May
31, 2007 (public review closing date) to be considered by the Agency.
All electronic comments should be formatted as Microsoft Word. Please
make reference to docket number NIOSH-099.
NIOSH seeks to obtain materials, including published and
unpublished reports and research findings, relevant to the
characterization of exposures and possible health risks of occupational
exposure to asbestos and other mineral fibers. Examples of requested
information include, but are not limited to, the following:
(1) Identification of industries, occupations, and processes where
exposure to mineral fibers may occur, including exposure to fiber-like
cleavage fragments and thoracic-sized fibers (as defined in the draft
NIOSH document).
(2) Current and historical mineral fibers exposure measurement
data, including exposure to fiber-like cleavage fragments and thoracic-
sized fibers at various types of industries and jobs.
(3) Case reports or other health information demonstrating health
effects in workers exposed to mineral fibers, including exposure to
fiber-like cleavage fragments and thoracic-sized fibers.
(4) Reports of experimental in vivo, in vitro, and inhalation
studies with rodents that provide evidence of biopersistence and/or of
a dose-relationship between the particle dimension (e.g., fiber) of the
mineral and its biological activity.
(5) Information on sampling and analytical methods that could be
used to improve the identification and differentiation of ``fibers'' of
different dimensions and composition.
(6) Information on technologies that could be used to separate
thoracic-sized fibers, including fiber-like cleavage fragments, into
discrete size dimensions in quantities sufficient for conducting
chronic rodent inhalation studies.
NIOSH will use this information to assess the scientific basis for
the draft document and the need to revise research recommendations.
Contact Person for Technical Information: Paul Middendorf,
telephone (513) 533-8606, M/S C-9, Robert A. Taft Laboratories, 4676
Columbia Parkway, Cincinnati, Ohio 45226.
Contact Person for Submitting Comments/Meeting Attendance: Diane
Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway, M/S C-34,
Cincinnati, Ohio 45226, telephone (513) 533-8450. All material
submitted to the Agency should reference Docket Number NIOSH-099.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Dated: April 18, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E7-7882 Filed 4-24-07; 8:45 am]
BILLING CODE 4163-19-P